_biomarkers-of-treatment-response-in-patients-with-mmr-proficient-crc-preview-1.jpg "Biomarkers of treatment response in patients with MMR-proficient CRC from regorafenib nivolumab asco Video Screenshot Preview 1")
Gallery_biomarkers-of-treatment-response-in-patients-with-mmr-proficient-crc-preview-3.jpg "Biomarkers of treatment response in patients with MMR-proficient CRC from regorafenib nivolumab asco Video Screenshot Preview 3")
Gallery_biomarkers-of-treatment-response-in-patients-with-mmr-proficient-crc-preview-hqdefault.jpg "Biomarkers of treatment response in patients with MMR-proficient CRC from regorafenib nivolumab asco Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 44 seconds
👁 View: 109 times
Play Audio:👁 View: 109 times
Description:
VJOncology
VJOncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_gi-asco-2020-recap-webinar.webp "Fight Colorectal Cancer")
_highlights-and-key-clinical-trial-updates-from-asco-gi-2022.webp "VJOncology")
_combination-therapy-updates-from-asco-2019.webp "OncLiveTV")
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.webp "VJOncology")
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.webp "VJOncology")
⏲ 2 minutes 52 seconds 👁 46
_the-rationale-for-combining-regorafenib-with-io-to-treat-patients-with-refractory-mss-crc.webp "VJOncology")
⏲ 1 minute 23 seconds 👁 48
_regorafenib-in-colorectal-cancer.webp "OncLiveTV")
_dr-lopes-on-the-fda-approval-of-nivolumab-ipilimumab-in-nsclc.webp "OncLiveTV")
Related Video Searches
Back to Search
Search Videos
Recent Searches
×
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
_gi-asco-2020-recap-webinar.jpg)
_highlights-and-key-clinical-trial-updates-from-asco-gi-2022.jpg)
_combination-therapy-updates-from-asco-2019.jpg)
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.jpg)
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.jpg)
_the-rationale-for-combining-regorafenib-with-io-to-treat-patients-with-refractory-mss-crc.jpg)
_regorafenib-in-colorectal-cancer.jpg)
_dr-lopes-on-the-fda-approval-of-nivolumab-ipilimumab-in-nsclc.jpg)
❮❯
1 / 12
2 / 12
3 / 12
4 / 12
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
5 / 12
6 / 12
7 / 12
8 / 12
9 / 12
10 / 12
11 / 12
12 / 12
View Full Screen: biomarkers of treatment response in patients with mmr proficient crc preview 1.jpg
![[+]](/images/menu.gif){kind=small}